These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2022 related articles for article (PubMed ID: 32182409)

  • 1. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.
    van Doremalen N; Bushmaker T; Morris DH; Holbrook MG; Gamble A; Williamson BN; Tamin A; Harcourt JL; Thornburg NJ; Gerber SI; Lloyd-Smith JO; de Wit E; Munster VJ
    N Engl J Med; 2020 Apr; 382(16):1564-1567. PubMed ID: 32182409
    [No Abstract]   [Full Text] [Related]  

  • 2. The reproductive number of COVID-19 is higher compared to SARS coronavirus.
    Liu Y; Gayle AA; Wilder-Smith A; Rocklöv J
    J Travel Med; 2020 Mar; 27(2):. PubMed ID: 32052846
    [No Abstract]   [Full Text] [Related]  

  • 3. Aerosol and surface persistence: Novel SARS-CoV-2 versus other coronaviruses.
    Krishan K; Kanchan T
    J Infect Dev Ctries; 2020 Jul; 14(7):748-749. PubMed ID: 32794465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
    Li YC; Bai WZ; Hashikawa T
    J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.
    Körner RW; Majjouti M; Alcazar MAA; Mahabir E
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32806708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Emerging Coronaviruses in Two Decades.
    Guarner J
    Am J Clin Pathol; 2020 Mar; 153(4):420-421. PubMed ID: 32053148
    [No Abstract]   [Full Text] [Related]  

  • 7. Put a lid on it: are faecal bio-aerosols a route of transmission for SARS-CoV-2?
    McDermott CV; Alicic RZ; Harden N; Cox EJ; Scanlan JM
    J Hosp Infect; 2020 Jul; 105(3):397-398. PubMed ID: 32315667
    [No Abstract]   [Full Text] [Related]  

  • 8. Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA; Rodriguez-Morales AJ
    J Hosp Infect; 2020 Jun; 105(2):111-112. PubMed ID: 32277963
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-Cov-2 (human) and COVID-19: Primer 2020.
    Ramakrishna G; Kumar P; Aggarwal S; Islam M; Singh R; Jagdish RK; Trehanpati N
    Hepatol Int; 2020 Jul; 14(4):475-477. PubMed ID: 32333304
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reaction of Sera from COVID-19 Patients with SARS-CoV Assays.
    Wan WY; Lim SH; Seng EH
    Ann Acad Med Singap; 2020 Jul; 49(7):523-526. PubMed ID: 33000119
    [No Abstract]   [Full Text] [Related]  

  • 11. Seasonality of Respiratory Viral Infections.
    Moriyama M; Hugentobler WJ; Iwasaki A
    Annu Rev Virol; 2020 Sep; 7(1):83-101. PubMed ID: 32196426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.
    Fears AC; Klimstra WB; Duprex P; Hartman A; Weaver SC; Plante KS; Mirchandani D; Plante JA; Aguilar PV; Fernández D; Nalca A; Totura A; Dyer D; Kearney B; Lackemeyer M; Bohannon JK; Johnson R; Garry RF; Reed DS; Roy CJ
    Emerg Infect Dis; 2020 Sep; 26(9):2168-71. PubMed ID: 32568661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplets and Aerosols in the Transmission of SARS-CoV-2.
    Meselson M
    N Engl J Med; 2020 May; 382(21):2063. PubMed ID: 32294374
    [No Abstract]   [Full Text] [Related]  

  • 14. Aerosol transmission of SARS-CoV-2: The unresolved paradox.
    Priyanka ; Choudhary OP; Singh I; Patra G
    Travel Med Infect Dis; 2020; 37():101869. PubMed ID: 32891726
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 Transmission and the Risk of Aerosol-Generating Procedures.
    Pasnick S; Carlos WG; Dela Cruz CS; Gross JE; Garrison G; Jamil S
    Am J Respir Crit Care Med; 2020 Aug; 202(4):P13-P14. PubMed ID: 32795140
    [No Abstract]   [Full Text] [Related]  

  • 16. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
    Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
    Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and Viability of SARS-CoV-2.
    Rubens JH; Karakousis PC; Jain SK
    N Engl J Med; 2020 May; 382(20):1962-1963. PubMed ID: 32283575
    [No Abstract]   [Full Text] [Related]  

  • 18. The COVID-19 pandemic in the USA: what might we expect?
    Chowell G; Mizumoto K
    Lancet; 2020 Apr; 395(10230):1093-1094. PubMed ID: 32247381
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability and Viability of SARS-CoV-2.
    Petti S
    N Engl J Med; 2020 May; 382(20):1964-1965. PubMed ID: 32283579
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability and Viability of SARS-CoV-2.
    Schwartz KL; Kim J; Garber G
    N Engl J Med; 2020 May; 382(20):1963. PubMed ID: 32283576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 102.